Resources from the same session
First-line treatment selection in metastatic hormone-sensitive prostate cancer (mHSPC)
Presenter: Deborah Mukherji
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
Progression of the case
Presenter: Marniza Saad
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
Pragmatic approach to treatment selection in metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Ravindran Kanesvaran
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
Use of PARP inhibitors in prostate cancer: Current data and future directions
Presenter: Arun Azad
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
PSMA imaging and theranostics
Presenter: Sue Ping Thang
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Transition from hormone-sensitive to castration-resistant prostate cancer
Resources:
Webcast